From the Russell H. Morgan Department of Radiology and Radiological Sciences, Johns Hopkins University School of Medicine, 600 N Wolfe St, Room 143, Baltimore, MD 21287
Auto-generated profile, based on publicly available information
Mounes Aliyari Ghasabeh
From the Russell H. Morgan Department of Radiology and Radiological Sciences, Johns Hopkins University School of Medicine, 600 N Wolfe St, Room 143, Baltimore, MD 21287
Recognizing the multimodality imaging features of the biliary system and liver parenchyma in primary sclerosing cholangitis can help the radiologist provide an accurate diagnosis, identify a differ... Primary sclerosing cholangitis (PSC) is a chronic progressive inflammatory disease of the bile ducts that leads to multifocal bile duct fibrosis, strictures, cholestasis, liver parenchymal changes,...
MRI-based R2* mapping enabled reproducible quantification of liver iron overload across four centers, three vendors, and three field strengths (1.5 T, 2.89 T, and 3.0 T). Background MRI is a standard of care tool to measure liver iron concentration (LIC). Compared with regulatory-approved R2 MRI, R2* MRI has superior speed and is available in most MRI scanners; howe...
Pancreatic cystic neoplasms 15–25 mm in size were most likely to show growth on follow-up images obtained with CT or MRI; however, very small lesions (<5 mm) showed no interval growth until at leas... Background Incidental detection of pancreatic cystic neoplasm (PCN) has increased. Since a small percentage of PCNs possess malignant potential, management is challenging. The recently revised Amer...
Purpose: To determine the performance of magnetic resonance (MR) imaging-based tumor metrics for evaluation of response to transarterial chemoembolization (TACE) in patients with unresectable intrahepatic cholangiocarcinoma (ICCA). Materials and Methods: Ninety-four patients with unresectable ICCA underwent baseline and follow-up MR imaging after TACE and were followed up until death or end of study duration. Lesions were analyzed for anatomic (Response Evaluation Criteria in Solid Tumors [RECIST] and tumor volume) and functional (viable tumor volume, viable tumor burden, and apparent diffusion coefficient [ADC]) volumetric MR parameters by using semiautomatic software. Response was assessed by using changes in viable tumor volume by using modified RECIST (mRECIST)-derived thresholds (three-dimensional mRECIST), viable tumor burden, and ADC. Overall survival was the primary endpoint. Cox-regression and Kaplan-Meier survival analysis were used. Results: Tumor volume did not change after TACE (P=.07) whereas RECIST diameter showed a small change (22.6%; P=.02). There was an increase in ADC (20.7%) and a decrease in viable tumor volume (229.3%) and viable tumor burden (229.1%; P<.001 for all). Higher overall survival was noted among responders by using thresholds of 25% increase in ADC, 66% decrease in viable tumor volume, and 50% decrease in viable tumor burden (log-rank test, P<.05). Hazard ratio for nonresponders by using ADC, three-dimensional mRECIST, and viable tumor burden at multivariable analysis was 2.9 (P=.004), 4.1 (P =.009), and 4.0 (P=.002), respectively. Survival differences were noted for patients who showed response by using all three parameters (ADC, three-dimensional mRECIST, and viable tumor burden) versus those who showed response by using either one or two of these parameters versus those who showed no response (P<.001). Conclusion: Changes in volumetric ADC, viable tumor volume, and viable tumor burden at MR imaging provide prognostic information among patients with unresectable ICCA who undergo TACE. (c) RSNA, 2018
The higher amount of epicardial fat in hearts with arrhythmogenic right ventricular dysplasia/cardiomyopathy, particularly surrounding the left ventricle, could provide an indicator for the degree ... Purpose To compare epicardial fat in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C) with that in healthy subjects. Materials and Methods In this retrospective stud...
Baseline multiparametric MRI assessment including volumetric apparent diffusion coefficient, percentage viable tumor volume, and viable tumor burden can help predict mortality risk in patients with unresectable intrahepatic cholangiocarcinoma undergoing transcatheter arterial chemoembolization. PurposeTo evaluate whether baseline MRI can help predict survival in patients with unresectable intrahepatic cholangiocarcinoma (ICCA) undergoing transcatheter arterial chemoembolization (TACE).Materials and MethodsThis retrospective study was compliant with HIPAA and approved by the institutional review board. The requirement to obtain informed consent was waived. The study included 111 patients (mean age, 62 years ± 12; range, 29–86 years), with 44 men (mean age, 61 years ± 12; range, 29–81 years) and 67 women (mean age, 63 years ± 12; range, 34–86 years). Patients underwent TACE after baseline MRI, which included contrast-enhanced and diffusion-weighted imaging with apparent diffusion coefficient (ADC) mapping between 2003 and 2016. The single largest tumor was assessed independently by a radiologist for anatomic and functional (viable tumor volume, percentage viable tumor volume [100 × viable tumor volume/whole tumor volume], viable tumor burden [100 × viable tumor volume/whole liver volume], and ADC)...